| Product Name |
Moxifloxacin Inhouse Impurity 16 / 7-((4aS,7aS)-1-(2-carboxyethyl)octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals |
| CAS No |
2489671-20-5 |
| Catalog Number |
GS.101.MOX.46 |
| Chemical Name/Synonyms |
7-((4aS,7aS)-1-(2-carboxyethyl)octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
| Molecular Weight |
473.5 |
| Molecular Formula |
C24H28FN3O6 |
| Purity |
NLT 95 % |
| Applications |
It is used in the treatment of respiratory tract infections, cellulitis, anthrax, endocarditis, meningitis, and tuberculosis. |
| Inventory Status |
customized
|
